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UV derivative spectrophotometry was used for quantitative
determination of hydroquinone in creams. The aim of this work
was to investigate optimum wavelength and order of derivative,
and to validate the proposed spectrophotometric method. The
results of standard curves were calculated and statistically analyzed
through the least squares method in the interval from 10.0 to
26.0 µg/mL, in the first, second, third and fourth order derivatives.
The quantitative determination was carried out by using the zero-
crossing (Z-C) and zero-peak (Z-P) methods. The proposed method
is simple, of low cost and provides reliable results in order to be
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The hyperpigmentary disorders of the skin are caused
by the over production of melanin, either by a normal or
increased number of melanocytes, or by hormonal disorders
(Cecil, 1993; Silva, Rezende, 1998). The hydroquinone
(HQ) has been used for decades in creams, gels and lotions
for the treatment of these disorders. It is the most frequently
used compound in skin-toning preparations (Palumbo et
al., 1991; Katsambas, Antoniou, 1995; Mohamed,
Mohamed, 1998). It belongs to the group of phenols and
alike most compounds of this group, it easily undergoes
oxidative degradation, principally in the presence of
metallic ions, high concentration of oxygen, high pH and on
exposure to light (Connors et al., 1986; Ullmann´s, 1999).
The effects of HQ are transitory and concentrations below
3.0% do not cause skin injuries, however concentration
above 5.0% could provoke local irritation being this the
main reason for the validation of a simple method (Bleehen,
1977; Hardman et al., 1996; Zanini and Oga, 1989).
Several analytical methods for the determination of
HQ in skin-toning preparations are described, including
high performance liquid chromatography (Firth, Rix, 1986;
Gagliardi et al., 1987; Borremans et. al., 1999), capillary
electrochromatography (Desiderio et al., 2000), micellar
chromatography (Sakodinskaya et al., 1992) and other
analytical techniques (Wang, 1995; Cruz, Fatibello-Filho,
2000; Rueda et al., 2003).
The HQ shows a broad band of absorption in the UV
region between 190 and 350 nm, whose spectrum can be
represented by the curve A = f (λ), where A is absorbance
and λ the wavelength. From this curve, successive
derivatives can be calculated at each point:
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With the obtained values, the differential curve can be
traced  giving rise to derivative spectrum of order n. The
derivative spectrophotometry is based on the use of these
spectra (Hackmann et al., 1991; Hopkala, Kowalczuk,
2000; Karpiñska, 2004).
The aim of this work was to determine most appropriate
wavelength, as well as order of the derivative for quantitative
determination of HQ in creams preparation (García et al.,
2005). Such selection contributes to the development and
validation of simple and reliable method for the quality control
of cream preparations containing this substance.
MATERIAL AND METHODS
Chemicals
Hydroquinone (99.8%), kindly supplied by Labora-
tórios Stiefel S.A. (São Paulo, Brasil), sulfuric acid
(analytical grade) Merck® (São Paulo, Brasil). Distilled
water was used to prepare all solutions.
Samples
The cream preparations were obtained from a local
compounding pharmacy. Sample I: 2 g HQ/100 g cream;
Sample II 4 g HQ/100 g cream and Sample III 4 g HQ/100 g
cream.
Instrumentation and analytical conditions
The methods were developed on a UV-Vis
spectrophotometer UV-1601 (Shimadzu®) using 1.0 cm
quartz cell and data were processed with online UVPC
v3.91 Personal Spectroscopy Software (Shimadzu®). The
wavelength interval was established between 190 and 350
nm, the delta lambda was 2 nm, the average screening speed
was 370 nm/min and the amplitude axis were from 0.000
to 1.200; -1.000 to 0.500; -0.200 to 0.120; -0.050 to 0.040
and -0.010 to 0.010 for zero, first, second, third and fourth
orders derivative spectra, respectively.
Selectivity
An amount of placebo cream equivalent to 20.0 mg
of HQ was weighed and transferred to a 100 mL graduated
becker. Approximately 50 mL of H2SO4 (0.05 M) was
added and was shaken during 10 min in a water bath at
40 °C. This solution was transferred to a 100 mL
volumetric flask and the volume was completed with the
same solvent. The solution was filtered through Whatman®
filter paper no.1, discarding first 5 mL. Appropriate
aliquots were diluted using sulfuric acid (0.05 M) in 50 mL
volumetric flask to obtain solutions with final concentration
equivalent to 16.0, 20.0 and 24.0 µg/mL of placebo.
Linearity
To prepare calibration curve, accurately weighed
50.0 mg of HQ was transferred to a 50 mL volumetric flask
and dissolved in sulfuric acid (0.05M). The volume was
completed with the same solvent. The above solution was
systematically diluted in 25 mL volumetric flasks (in
triplicate) to obtain final solutions containing 10.0, 14.0,
18.0, 22.0 and 26.0 µg/mL of HQ.
Precision
Accurately weighed amount of cream equivalent to
15.0 mg of HQ was transferred to a 100 mL graduated
becker. Approximately 50 mL of H2SO4 (0.05 M) were
added and were shaken during 10 min in a water bath at
40 ºC. This solution was transferred to a 100 mL volumetric
flask and the volume was completed with the same solvent.
The resultant solution was filtered through Whatman
filter paper no.1, discarding first 5 mL. A 3 mL aliquot of
this solution was diluted in a 25 mL volumetric flask using
0.05 M sulfuric acid to obtain a solution with final
concentration of 18.0 µg/mL. Each sample was assayed ten
times with each sample solution.
Accuracy
An accurately weighed amount of cream equivalent
to 12.0 mg of hydroquinone was transferred to a 100 mL
volumetric flask, dissolved in approximately 50 mL of
0.05 M sulfuric acid and was shaken during 10 min in a
water bath at 40 °C. After cooling, the volume was
completed with the same solvent and aliquots of 10.0 mL
of this solution were transferred into 100 mL volumetric
flasks containing 1.0, 5.0 and 10.0 mL of a standard
hydroquinone solution (100.0 µg/mL) and sulfuric acid
(0.05 M) was added to make up the volume to obtain final
concentrations of 13.2, 18.0 and 24.0 µg/mL of HQ. All
solutions were prepared in triplicate and analyzed. The
percentage recovery was calculated using the equation
proposed in Official Methods of Analysis of AOAC
International (AOAC International, 1990).
Procedure
After homogenization of the solutions and calibration
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of the spectrophotometer with 0.05 M sulfuric acid, the
absorption spectra of each sample were obtained. The first,
second, third and fourth orders derivative spectra were
traced from above curves. The quantitative determinations
of HQ were made at signal when there was no interfering
absorption.
RESULTS AND DISCUSSIONS
The calibration curves were constructed by plotting
amplitudes of the first, second, third and fourth derivative
spectra versus the concentration of the HQ in 0.05 M
sulfuric acid. Table I shows statistically treated data of
calibration curves.
Zero-crossing (Z-C) is the method that enables the
measurement of the spectrum amplitude where the
interference is cancelled till the signal of the HQ. Zero-peak
(Z-P) is the method that measures the spectrum amplitude
from the base line till the signal of HQ. These two methods
were used for quantitative determination of HQ in creams.
Figure 1 shows the zero, first, second, third and fourth
orders derivative spectra of the calibration curves of HQ in
0.05 M sulfuric acid. It was observed that at designated
points, the possible interference from placebo is null. These
are the most appropriate wavelengths for quantitative
determination of HQ. However, between these points, there
is a single wavelength that provides statistically most
adequate result and at this point, determination can be made
with least relative standard deviation.
After identifying the optimum wavelength and
derivative order by statistic treatment (signal at 302.0 nm
in the first derivative), the analytical method was validated
and applied for quantitative determination of HQ in creams.
The results can be observed in Table II. The low relative
standard deviation (R.S.D.) values indicates precision of
the method. In majority of the determinations it is below
2%, indicating high degree of agreement (repeatability)
between experimental values (Bruce et al., 1998; ICH
Q2A; ICH Q2B; Shabir, 2003). Figure 2 shows UV
derivative spectra of HQ standard solution, HQ sample
solution and placebo of the cream. No interfering signals
and overlaps were observed in placebo at 302.0 nm in the
first derivative. A good accuracy of the method was verified
with a mean recovery of 99.2% (Table III).
CONCLUSIONS
The proposed UV derivative spectrophotometric
method proved to be an excellent option for HQ
determination in creams. The interference from excipients
was eliminated by selecting the most adequate wavelength.
The first derivative with zero-peak method at 302.0 nm was
successfully applied for quantitative determination of HQ.
The proposed method can be used for analysis in routine
quality control of cosmetic preparations with HQ as a
unique active substance. The method is simple, rapid, pre-
cise and of low cost.
TABLE I - Statistics evaluation of the calibration curves of HQ in 0.05 M sulfuric acid
Derivative λ Method Regression equation (interval Correlation R.S.D. (%) Test “a”
(nm) 10.0 - 26.0 µg/mL) coefficient intercept
1 D 225.8 Z – C y=-2.64x10-2x + 1.03x10-2 -0.9923 1.6272 0.9171
1 D 302.0 Z – P y=-1.76x10-2x + 1.41x10-3 -0.9993 1.5051 0.1985
2 D 242.8 Z – C y=1.04x10-3x – 1.28x10-3 0.9989 2.0334 2.4237
2 D 267.8 Z – C y=5.28x10-4x + 6.50x10-5 0.9976 2.7741 0.1643
2 D 306.4 Z – P y=1.97x10-3x + 4.50x10-5 0.9990 1.7709 0.048
3 D 221.8 Z – C y=-7.48x10-4x – 6.50x10-5 -0.9992 1.5218 0.2118
3 D 232.0 Z – P y=8.15x10-4x + 3.10x10-4 0.9991 1.5984 0.8679
3 D 302.4 Z – P y=4.70x10-4x + 2.60x10-4 0.9988 1.9189 1.0417
3 D 311.2 Z – P y=-2.30x10-4x + 4.00x10-5 -0.9990 1.7812 0.3672
4 D 217.4 Z – C y=-3.30x10-4x – 1.40x10-4 -0.9981 2.4023 0.6426
4 D 235.4 Z – C y=-1.32x10-4x – 2.15x10-4 -0.9841 6.6986 0.8276
4 D 305.6 Z – P y=-1.15x10-4x – 9.00x10-5 -0.9962 3.3810 0.8262
4 D 313.4 Z – P y=3.25x10-5x – 2.50x10-5 0.9912 5.6469 0.521
(Standard solutions n = 5); R.S.D. = Relative Standard Deviation; Z-C = Zero-Crossing; Z-P = Zero-Peak
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FIGURE 1 - Absorption spectra of zero (a), first (b), second (c), third (d) and fourth (e) derivative of HQ solutions
(–––––) and placebos (-----) in 0.05 M sulfuric acid. Concentrations of 10.0, 14.0, 18.0, 22.0 and 26.0 µg/mL of HQ and
16.0, 20.0 and 24.0 µg/mL of placebo.
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TABLE II - Determination of the HQ content in cream utilizing the first, second, third and fourth derivative orders in 0.05 M
sulfuric acid
Declared amount Found amount * Amount R. S. D. C. I.
Sample HQ (g/100 g) HQ (g/100 g) (%) (%) P = 95 %
First derivative 302.0 nm
I 2 1.870 93.5 0.968 0.12
II 4 3.916 97.9 0.854 0.11
III 4 4.057 101.4 0.812 0.11
Second derivative 306.4 nm
I 2 1.870 93.5 1.174 0.14
II 4 3.876 96.9 1.463 0.18
III 4 4.012 100.3 1.121 0.14
Third derivative 221.8 nm
I 2 1.873 93.6 2.363 0.28
II 4 3.873 96.8 1.331 0.16
III 4 3.988 99.7 1.432 0.18
Fourth derivative 217.4 nm
I 2 1.717 85.8 1.994 0.22
II 4 3.664 91.6 1.292 0.15
III 4 3.678 91.9 0.869 0.12
* n = 10; R.S.D. = Relative Standard Deviation; C.I. = Confidence Interval
FIGURE 2 - UV derivative spectra of (a) HQ standard solution, (b) HQ sample III solution and (c) placebo of the cream
in 0.05 M sulfuric acid. Concentration 18.0 µg of HQ/mL.
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RESUMO
Determinação do comprimento de onda ótimo e da
ordem da derivada em espectrofotometria para
quantificação de hidroquinona em cremes
A espectrofotometria derivada no UV foi usada para a de-
terminação quantitativa de hidroquinona em cremes. O
objetivo desta pesquisa foi investigar o melhor compri-
mento de onda e a ordem da derivada, bem como validar
o método proposto. Os resultados das curvas analíticas fo-
ram analisados estatisticamente pelo método dos mínimos
quadrados no intervalo de 10,0 a 26,0 µg/mL, na primei-
ra, segunda, terceira e quarta ordens da derivada. As de-
terminações quantitativas foram realizadas utilizando os
métodos “zero-crossing (Z-C)” e zero-pico (Z-P). O mé-
todo proposto é simples, de baixo custo e fornece resulta-
dos confiáveis podendo ser usado no controle de qualida-
de de cremes contendo hidroquinona como substância
ativa.
UNITERMOS: Hidroquinona. Espectrofotometria deriva-
da no UV. Controle de qualidade
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